Malaysia · Delayed Price · Currency is MYR Duopharma Biotech Berhad Company Description
Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally.
The company offers consumer healthcare products, such as vitamins, minerals, and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others.
It also provides specialty pharmaceutical drugs for targeted conditions, biosimilar products, and medical devices and consumables to patients with conditions, including diabetes, cancer, cardiovascular, renal, and other diseases.
The company’s product portfolio includes covasc, crystorvas, and vytocor; lebreta, and krabeva; and unihepa, erysaa, bi-haemosol, and haemosol.
In addition, it offers its products under the Champs, Flavettes, Eye Glo, Proviton, Naturalle, IRORO Nutreatment, and Uphamol brands.
The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019.
The company was founded in 1978 and is based in Klang, Malaysia.
| Country | Malaysia |
| Founded | 1978 |
| Industry | Pharmaceutical Preparations |
| Employees | 1,957 |
| CEO | Ariff bin Abdul Shatar |
Contact Details
Address: Jalan Seruling 59 Klang, 41200 Malaysia | |
| Phone | 60 3 3323 2759 |
| Website | duopharmabiotech.com |
Stock Details
| Ticker Symbol | DPHARMA |
| Exchange | Bursa Malaysia |
| Fiscal Year | January - December |
| Reporting Currency | MYR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ariff bin Abdul Shatar | Chief Executive Officer |
| Wu Chek | Chief Financial Officer |
| Wan Bin Wan Abdul Majid | Chief Operating Officer |